Wendell Garcia-Ortiz, MD
Internal Medicine · South Bend, INNPI 1972593630
Payments from drug & device makers
Across 98 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$531
- Lilly USA, LLC$237
- Regeneron Healthcare Solutions, Inc.$190
- E.r. Squibb & Sons, L.L.C.$179
- Johnson & Johnson$131
- AbbVie$112
- plus $586 from 11 others
What the payments were for
- Food & beverage$1,966100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 35 | $531 |
| Lilly USA, LLC | 8 | $237 |
| Regeneron Healthcare Solutions, Inc. | 6 | $190 |
| E.r. Squibb & Sons, L.L.C. | 9 | $179 |
| Johnson & Johnson | 6 | $131 |
| AbbVie | 5 | $112 |
| Sanofi | 6 | $108 |
| Amgen | 5 | $108 |
| Sun Pharmaceutical Industries Inc. | 3 | $63 |
| Incyte Corporation | 2 | $59 |
| Pfizer | 4 | $56 |
| UCB, Inc. | 2 | $56 |
| Organogenesis Inc. | 2 | $45 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| LEO Pharma Inc. | 2 | $26 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$1,966 in reported general payments places this provider in the 80th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 67 | $8,122 |
| Ketoconazole | 150 | $2,560 |
| Metronidazole | 52 | $2,116 |
| Triamcinolone Acetonide | 170 | $2,009 |
| Fluocinonide | 49 | $1,762 |
| Clindamycin Phosphate | 56 | $1,414 |
| Doxycycline Hyclate | 60 | $1,180 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $843 |
| Clobetasol Propionate | 26 | $814 |
| Pimecrolimus | 11 | $723 |
| Mupirocin | 107 | $645 |
| Ciclopirox | 18 | $441 |
| Hydroxyzine Hcl | 29 | $262 |
| Cephalexin | 32 | $251 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $152 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in South Bend
- Rita SchmidSouth Bend$599K
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.